510(k) Report

510(k) · Cleared

Cleared

Trufill DCS Orbit Detachable Coil and Trufill DCS Syringe or Trufill DCS Syringe II, Also Known as the Trufill DCS Orbit

K080967510(k) SpecialCleared May 2, 200828-day reviewClass II21 CFR 882.5950

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cordis Neurovascular, Inc. · HCG Device, Neurovascular Embolization

Cleared on May 2, 2008 after a 28-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 4 later devices descend from it.

Decided
May 2, 2008
Review
28 days
Class
Class II
Product code
HCG
Recalls
None
Predicates
0

4 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2013: 1 descendant cleared2010: 1 descendant cleared2012: 1 descendant cleared2014: 1 descendant cleared20052010201520202025
  1. This deviceK080967 Trufill DCS Orbit Detachable Coil and Trufill DCS Syringe or Trufill…Cordis Neurovascular, Inc. · 2008
  2. Descendant · cites it directly · 2 of its ownK093973 Trufill DCS Orbit Detachable Coil SystemCodman & Shurtleff, Inc. · 2010
  3. Descendant · 2 generations on · 1 of its ownK120686 Orbit Galaxy G2 Microcoil Delivery SystemCodman & Shurtleff, Inc. · 2012
  4. Descendant · 3 generations on · 0 of its ownK142429 CODMAN Microcoil Delivery System, DELTAMAXX Microcoil Delivery…Codman & Shurtleff, Inc. · 2014
  5. Descendant · cites it directly · 0 of its ownK123560 Vascular Occlusion System (Trufill Pushable Coils), and Trufill DCS…Codman & Shurtleff, Inc. · 2013

Most influential descendants

Showing 4 of 4 · See all
  • K093973Trufill DCS Orbit Detachable Coil SystemCodman & Shurtleff, Inc. · 2010 · cites it directly2descendants
  • K120686Orbit Galaxy G2 Microcoil Delivery SystemCodman & Shurtleff, Inc. · 2012 · 2 generations on1descendant
  • K142429CODMAN Microcoil Delivery System, DELTAMAXX Microcoil Delivery System, ORBIT GALAXY G2…Codman & Shurtleff, Inc. · 2014 · 3 generations on0descendants
  • K123560Vascular Occlusion System (Trufill Pushable Coils), and Trufill DCS Orbit Detachable…Codman & Shurtleff, Inc. · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K080967Trufill DCS Orbit Detachable Coil and Trufill DCS Syringe or Trufill DCS…Cordis Neurovascular, Inc.2008—
+1K093973Trufill DCS Orbit Detachable Coil SystemCodman & Shurtleff, Inc.2010—
+2K120686Orbit Galaxy G2 Microcoil Delivery SystemCodman & Shurtleff, Inc.2012—
+3K142429CODMAN Microcoil Delivery System, DELTAMAXX Microcoil Delivery System, ORBIT…Codman & Shurtleff, Inc.2014—
+1K123560Vascular Occlusion System (Trufill Pushable Coils), and Trufill DCS Orbit…Codman & Shurtleff, Inc.2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201210
201310
201410
FIG. 1 — Lineage of K080967, 2008–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HCG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HCG device

  1. #1 K252700 Optima Coil System (Optima Packing Coil System)score 20.6 · 26 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K093973Trufill DCS Orbit Detachable Coil SystemCodman & Shurtleff, Inc.20102
K123560Vascular Occlusion System (Trufill Pushable Coils), and Trufill DCS Orbit Detachable…Codman & Shurtleff, Inc.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K093973 (Codman & Shurtleff, Inc., 2010) has gone furthest, with 2 descendants of its own.

How does its category compare?

All HCG devices

HCG Device, Neurovascular Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · HCG

3in 2025

2007: 82008: 92009: 72010: 82011: 92012: 72013: 72014: 52015: 52016: 72017: 52018: 42019: 12020: 22021: 52022: 32023: 22024: 42025: 32026 (partial year): 4
2007high 9 (2008) · low 1 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HCG

107in 2025

2007: 50 days median2008: 71 days median2009: 48 days median2010: 72 days median2011: 78 days median2012: 30 days median2013: 67 days median2014: 66 days median2015: 60 days median2016: 37 days median2017: 97 days median2018: 173 days median2021: 103 days median2022: 114 days median2024: 49 days median2025: 107 days median2026 (partial year): 30 days median
2007high 173 (2018) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HCG

1in 2025

2007: 12008: 32010: 22011: 12013: 22014: 42022: 22024: 12025: 1, 1 Class I2026 (partial year): 1
2007high 4 (2014) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · HCG

537in 2025

2007: 3262008: 7302009: 8212010: 8512011: 8942012: 1,1462013: 1,1032014: 1,7292015: 1,5982016: 1,9912017: 2,4942018: 2,0582019: 1,7632020: 1,7542021: 2,2682022: 6632023: 5682024: 5522025: 537
2007high 2,494 (2017) · low 326 (2007)2025

MAUDE reports naming product code HCG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078501326
20089713730
20097480821
20108722851
20119781894
201273001,146
201376721,103
201456641,729
201556001,598
201673701,991
201759702,494
2018417302,058
20191—01,763
20202—01,754
2021510302,268
202231142663
20232—0568
20244491552
202531071 (1)537
20264301—

What is it indicated for?

The TRUFILL DCS ORBIT Detachable Coil is indicated for embolizing intracranial aneurysms and other vascular malformations such as arteriovenous malformations and arteriovenous fistulae of the neurovasculature.

The TRUFILL DCS ORBIT Detachable Coil is also intended for arterial and venous embolization in the peripheral vasculature.

The TRUFILL® DCS Syringe is indicated for use with the TRUFILL® family of Detachable Coils.

The TRUFILL® DCS Syringe II is indicated for use with the TRUFILL® family of Detachable Coils.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K080967: Trufill DCS Orbit Detachable Coil and Trufill DCS Syringe or Trufill DCS Syringe II, Also Known as the Trufill DCS Orbit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K080967

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026